News coverage about NanoString Technologies (NASDAQ:NSTG) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. NanoString Technologies earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 47.0070556674004 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Shares of NanoString Technologies (NASDAQ NSTG) traded down $0.04 during mid-day trading on Friday, reaching $8.36. The company’s stock had a trading volume of 122,867 shares, compared to its average volume of 299,593. The company has a debt-to-equity ratio of 1.08, a quick ratio of 2.89 and a current ratio of 3.35. NanoString Technologies has a 12 month low of $7.32 and a 12 month high of $23.43.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings data on Thursday, November 2nd. The biotechnology company reported ($0.45) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.11. The company had revenue of $27.02 million for the quarter, compared to analyst estimates of $26.27 million. NanoString Technologies had a negative return on equity of 174.55% and a negative net margin of 44.24%. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted ($0.51) EPS. sell-side analysts expect that NanoString Technologies will post -1.77 EPS for the current year.

A number of equities research analysts recently issued reports on NSTG shares. Zacks Investment Research raised shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Tuesday, July 25th. BidaskClub cut shares of NanoString Technologies from a “sell” rating to a “strong sell” rating in a research note on Friday, July 28th. Cowen and Company reissued a “buy” rating and issued a $20.00 price target on shares of NanoString Technologies in a research note on Thursday, September 28th. Janney Montgomery Scott cut shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a research note on Thursday, October 12th. Finally, Robert W. Baird dropped their price target on shares of NanoString Technologies from $23.00 to $19.00 and set an “outperform” rating on the stock in a research note on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $17.25.

COPYRIGHT VIOLATION NOTICE: This piece was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Insider Buying and Selling by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Stock Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related stocks with our FREE daily email newsletter.